deltatrials
Completed EARLY_PHASE1 INTERVENTIONAL 3-arm NCT03678012

Evaluation of Anti-biofilm Effects of Ferumoxytol (Feraheme) Using an in Situ Biofilm Demineralization Model

Sponsor: Indiana University

Conditions Dental Caries
Interventions Ferumoxytol/Hydrogen peroxide Hydrogen Peroxide Water
Updated 4 times since 2018 Last updated: Sep 17, 2018 Started: Jun 7, 2018 Primary completion: Aug 16, 2018 Completion: Aug 16, 2018
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This EARLY_PHASE1 trial investigates Dental Caries and is currently completed. Indiana University leads this study, which shows 4 recorded versions since 2018 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

~Oct 2018 – ~Jan 2021 · 27 months · monthly snapshotCompleted~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – present · 22 months · monthly snapshotCompleted

Change History

4 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed EARLY_PHASE1

  2. Jul 2024 — Sep 2024 [monthly]

    Completed EARLY_PHASE1

  3. Jan 2021 — Jul 2024 [monthly]

    Completed EARLY_PHASE1

  4. Oct 2018 — Jan 2021 [monthly]

    Completed EARLY_PHASE1

    First recorded

Jun 2018

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Indiana University
  • University of Pennsylvania
Data source: University of Pennsylvania

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations